Scatena, Roberto
 Distribuzione geografica
Continente #
EU - Europa 2.478
NA - Nord America 2.182
AS - Asia 849
AF - Africa 11
SA - Sud America 7
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.534
Nazione #
US - Stati Uniti d'America 2.158
DE - Germania 553
RU - Federazione Russa 519
CN - Cina 416
SE - Svezia 363
UA - Ucraina 311
SG - Singapore 168
IT - Italia 153
PL - Polonia 143
IE - Irlanda 114
TR - Turchia 92
FR - Francia 86
FI - Finlandia 78
ID - Indonesia 68
GB - Regno Unito 65
IN - India 48
BE - Belgio 21
CA - Canada 21
ES - Italia 18
JP - Giappone 14
NL - Olanda 14
KR - Corea 12
RO - Romania 9
CH - Svizzera 7
HK - Hong Kong 6
IR - Iran 6
CZ - Repubblica Ceca 5
MA - Marocco 5
VN - Vietnam 5
IQ - Iraq 4
AU - Australia 3
BR - Brasile 3
BY - Bielorussia 3
CO - Colombia 3
MX - Messico 3
PK - Pakistan 3
TW - Taiwan 3
BG - Bulgaria 2
DK - Danimarca 2
EU - Europa 2
GR - Grecia 2
LT - Lituania 2
NG - Nigeria 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
CI - Costa d'Avorio 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KZ - Kazakistan 1
ME - Montenegro 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
ZA - Sudafrica 1
Totale 5.534
Città #
Chandler 406
Jacksonville 157
Warsaw 142
Ashburn 131
Singapore 126
San Mateo 116
Dublin 109
Nanjing 106
Wilmington 84
Woodbridge 69
Ann Arbor 68
New York 68
Jakarta 64
Izmir 62
Houston 61
Fairfield 58
Dearborn 57
Beijing 48
Lawrence 45
Redmond 43
Boston 41
Seattle 41
Cattolica 37
Moscow 33
Bremen 27
Chicago 25
Mountain View 25
Kunming 23
Redwood City 23
Shanghai 23
Cambridge 22
Nürnberg 20
Boardman 19
Detroit 18
Helsinki 18
Nanchang 18
Princeton 18
Shenyang 17
Zhengzhou 17
Hangzhou 16
Milan 16
Rome 16
Brussels 15
Hebei 15
Lancaster 13
University Park 13
Marseille 12
Philadelphia 12
Jiaxing 11
Changsha 10
Los Angeles 9
Pune 9
Tianjin 9
Toronto 9
Edinburgh 8
Guangzhou 8
Hefei 7
Lanzhou 7
Simi Valley 7
Indiana 6
London 6
Madrid 6
Norwalk 6
Renton 6
San Jose 6
Centrale 5
Ottawa 5
Seoul 5
Augusta 4
Hong Kong 4
Istanbul 4
Lansing 4
Littleton 4
Santa Clara 4
Xian 4
Zurich 4
Bern 3
Brea 3
Busto Arsizio 3
Changchun 3
Ciampino 3
Erlangen 3
Falls Church 3
Fremont 3
Guidonia 3
Hanoi 3
Kish 3
Leawood 3
Lindewitt 3
Medan 3
Menlo Park 3
Minsk 3
Monza 3
Najaf 3
Phoenix 3
Salé 3
San Diego 3
San Francisco 3
Sivas 3
Timisoara 3
Totale 2.862
Nome #
FUNCTIONAL ALTERATIONS IN ADULT AND FETAL HEMOGLOBIN SASSARI ASP-ALPHA-126(H9) -] HIS - THE ROLE OF ALPHA(1)ALPHA(2) CONTACT 555
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing 336
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects 149
Advances in Cancer Biomarkers - From biochemistry to clinic for a critical revision 144
Advances in Cancer Stem Cell Biology 126
CA 19-9: Biochemical and Clinical Aspects 122
MITOCHONDRIAL DAMAGE AND METABOLIC COMPENSATORY MECHANISMS INDUCED BY HYPEROXIA IN U-937 CELL LINE. 114
3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 3. Discovery of Novel Lead Compounds Through Structure-Based Drug Design and Docking Studies 113
Neuron Specific Enolase as a biomarker: biochemical and clinical aspects 109
Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology. 107
Derangement of erythrocytic AE1 in beta-thalassemia by caspase 3: pathogenic mechanisms and implications in red blood cell senescence 104
An update on pharmacological approaches to neurodegenerative diseases. 102
A proteomic approach to characterizing ciglitazone-induced cancer cell differentiation in Hep-G2 cell line 102
A Critical Approach to Clinical Biochemistry of Chromogranin A 102
The Role of CA 125 as Tumor Marker: Biochemical and Clinical Aspects 97
Prognostic value of the reactive oxygen species in severe sepsis and septic shock patients: a-pilot study 97
A two-dimensional electrophoresis preliminary approach to human hepatocarcinoma differentiation induced by PPAR-agonists. 94
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 2. Effect of Pyrrole C2 and/or C4 Substitutions on Biological Activity 93
Mitochondrial proteomic approaches for new potential diagnostic and prognostic biomarkers in cancer 93
The epithelial–mesenchymal transition in cancer: a potential critical topic for translational proteomic research 91
The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. 90
Bezafibrate Induces a Mitochondrial Derangement in Human Cell Lines. Intriguing Effects for a Peroxisome Proliferator. 89
Advances in Mitochondrial Medicine 86
Circulating tumour cells and cancer stem cells: A role for proteomics in defining the interrelationships between function,phenotype and differentiation with potential clinical applications. 84
Immunological role of IgG subclasses 83
Modulation of cancer cell line differentiation: A neglected proteomic analysis with potential implications in pathophysiology, diagnosis, prognosis, and therapy of cancer. 82
Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy 81
CA 19-9: Biochemical and Clinical Aspects 81
Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential. 80
Cancer Stem Cells: An Innovative Therapeutic Approach 78
A critical approach to clinical biochemistry of Chromogranin A 78
Cancer Biomarkers: A Status Quo 77
Oxygen transport by Fetal Bovine Hemoglobin 76
Immunological role of IgG subclasses 75
Mitochondrial respiration and differentiation 72
The proteomics of cancer stem cells. Potential clinical applications for innovative research in oncology 71
Cancer stem cells: the development of new cancer therapeutics 69
The role of CA 125 as tumor marker: biochemical and clinical aspects 67
Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implications 66
Cancer Stem Cells: Proteomic Approaches for New Potential Diagnostic and Prognostic Biomarkers 66
CA 19-9: Biochemical and Clinical Aspects 66
Glycated human hemoglobin (HbA1c): functional characteristics and molecular modeling studies 64
Advances in Heat Shock Proteomics: Towards a Better Understanding of the Physiology and Pathophysiology of Molecular Chaperones. 62
Cellular respiration and dedifferentiation 61
Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks. 60
EFFECTS OF GEMFIBROZIL ON THE OXYGEN-TRANSPORT PROPERTIES OF ERYTHROCYTES 60
Toward the Standardization of Mitochondrial Proteomics: The Italian Mitochondrial Human Proteome Project Initiative 60
Glycolytic enzyme inhibitors in cancer treatment. 59
SEPARATION OF REDUCED AND OXIDIZED GLUTATHIONE BY MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY 59
Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation growth inhibition and terminal cell differentiation 58
THE MULTIPLE FUNCTIONS OF HEMOGLOBIN 58
Aroyl-Pyrrolyl Hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetilase inhibition 57
Cancer Stem Cells: A Revisitation of the “Anaplasia” Concept. In Advances in Cancer Stem Cell Biology 53
Resveratrol treatment induces redox stress in red blood cells: a possible role of caspase 3 in metabolism and anion transport 53
Cytotoxicity of a new endodontic filling material 52
Aroyl-pyrrolyl hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetylase inhibition. 45
The plasma membrane of erythrocytes plays a fundamental role in the transport of oxygen, carbon dioxide and nitric oxide and in the maintenance of the reduced state of the heme iron. 45
PHYSIOLOGICAL RELEVANCE OF THE OVERALL DELTA-H OF OXYGEN BINDING TO FETAL HUMAN HEMOGLOBIN 40
Exploring the connection unit in the HDAC inhibitor pharmacophore model: novel uracil-based hydroxamates. 38
Nitroflurbiprofen (NicOx). 37
Mitochondria and cancer: a growing role in apoptosis, cancer cell metabolism and dedifferentiation 36
Mitochondria and drugs 30
Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key? 30
Totale 5.584
Categoria #
all - tutte 20.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.269


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020396 0 0 0 0 19 43 97 35 36 22 72 72
2020/2021594 46 68 13 63 75 53 61 5 81 18 97 14
2021/2022567 48 69 9 59 32 24 14 91 17 26 73 105
2022/20231.663 154 191 94 169 94 137 29 118 583 26 52 16
2023/2024458 25 142 5 12 19 75 16 22 5 23 63 51
2024/2025271 34 25 85 35 92 0 0 0 0 0 0 0
Totale 5.584